Oral GLP-1 pipeline overview — all agents in development

Found this through search years later and it is still the best discussion of the question, so adding one thing. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

One thing that is still open after NurseAsh_DET’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

VanRx_Mike said:

For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

I read this differently from VanRx_Mike, on substance rather than tone. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

VanRx_Mike said:

For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.

Ask again with the specifics and you will get a better answer than this one.

VanRx_Mike said:

For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This is exactly what I could not find anywhere else. Adding it to my notes with a link back to this thread.